123I-labeled HIV-1 tat peptide radioimmunoconjugates are imported into the nucleus of human breast cancer cells and functionally interact in vitro and in vivo with the cyclin-dependent kinase inhibitor, p21(WAF-1/Cip-1)
- PMID: 17021818
- DOI: 10.1007/s00259-006-0189-0
123I-labeled HIV-1 tat peptide radioimmunoconjugates are imported into the nucleus of human breast cancer cells and functionally interact in vitro and in vivo with the cyclin-dependent kinase inhibitor, p21(WAF-1/Cip-1)
Abstract
Purpose: To evaluate the internalization and nuclear translocation of (123)I-tat-peptide radioimmunoconjugates in MDA-MB-468 breast cancer cells and their ability to interact with the cyclin-dependent kinase inhibitor, p21(WAF-1/Cip-1).
Methods: Peptides [GRKKRRQRRRPPQGYGC] harboring the nuclear-localizing sequence from HIV tat domain were conjugated to anti-p21(WAF-1/Cip-1) antibodies. Immunoreactivity was assessed by Western blot using lysate from MDA-MB-468 cells exposed to EGF to induce p21(WAF-1/Cip-1). Internalization and nuclear translocation were measured. The ability of tat-anti-p21(WAF-1/Cip-1) to block G(1)-S phase arrest in MDA-MB-468 cells caused by EGF-induced p21(WAF-1/Cip-1) was evaluated. Tumor and normal tissue uptake were determined at 48 h p.i. in athymic mice implanted s.c. with MDA-MB-468 xenografts injected intratumorally with EGF.
Results: There was 13.4+/-0.2% of radioactivity internalized by MDA-MB-468 cells incubated with (123)I-tat-anti-p21(WAF-1/Cip-1) and 34.6+/-3.1% imported into the nucleus. Tat-anti-p21(WAF-1/Cip-1)(8 muM) decreased the proportion of EGF-treated cells in G(1) phase from 81.9+/-0.7% to 46.1+/-0.7% (p<0.001), almost restoring the G(1) phase fraction to that of unexposed cells (25.8+/-0.2%). Non-specific tat-mouse IgG did not block EGF-induced G(1)-S phase arrest. Tumor uptake of radioactivity was higher in mice injected with EGF to induce p21(WAF-1/Cip-1) than in mice not receiving EGF (3.1+/-0.4% versus 1.8+/-0.2% ID/g; p=0.04). Western blot analysis of tumors revealed a threefold increase in the p21(WAF-1/Cip-1)/beta-actin ratio.
Conclusion: We conclude that intracellular and nuclear epitopes in cancer cells can be functionally targeted with tat-radioimmunoconjugates to exploit many more epitopes for imaging and radiotherapeutic applications than have previously been accessible.
Comment in
-
Cell-penetrating peptides and antibodies: a new direction for optimizing radioimmunotherapy.Eur J Nucl Med Mol Imaging. 2007 Jul;34(7):973-7. doi: 10.1007/s00259-007-0395-4. Eur J Nucl Med Mol Imaging. 2007. PMID: 17453198 No abstract available.
Similar articles
-
Antisense imaging of epidermal growth factor-induced p21(WAF-1/CIP-1) gene expression in MDA-MB-468 human breast cancer xenografts.Eur J Nucl Med Mol Imaging. 2003 Sep;30(9):1273-80. doi: 10.1007/s00259-003-1134-0. Epub 2003 Mar 15. Eur J Nucl Med Mol Imaging. 2003. PMID: 12640557
-
HIV-1 Tat peptide immunoconjugates differentially sensitize breast cancer cells to selected antiproliferative agents that induce the cyclin-dependent kinase inhibitor p21WAF-1/CIP-1.Bioconjug Chem. 2006 Sep-Oct;17(5):1280-7. doi: 10.1021/bc060053r. Bioconjug Chem. 2006. PMID: 16984139
-
Site-specific conjugation of HIV-1 tat peptides to IgG: a potential route to construct radioimmunoconjugates for targeting intracellular and nuclear epitopes in cancer.Eur J Nucl Med Mol Imaging. 2006 Mar;33(3):301-10. doi: 10.1007/s00259-005-1908-7. Epub 2005 Oct 29. Eur J Nucl Med Mol Imaging. 2006. PMID: 16258763
-
Anti-mouse monoclonal antibody immunoglobulin G conjugated to GRKKRRQRRRPPQGYG-diethylenetriamine pentaacetic acid-[111In].2008 Jan 16 [updated 2008 Feb 20]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2008 Jan 16 [updated 2008 Feb 20]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 20641335 Free Books & Documents. Review.
-
Cellular penetration and nuclear importation properties of 111In-labeled and 123I-labeled HIV-1 tat peptide immunoconjugates in BT-474 human breast cancer cells.Nucl Med Biol. 2007 Jan;34(1):37-46. doi: 10.1016/j.nucmedbio.2006.10.008. Nucl Med Biol. 2007. PMID: 17210460
Cited by
-
Radioimmunotheragnosis in Cancer Research.Cancers (Basel). 2024 Aug 20;16(16):2896. doi: 10.3390/cancers16162896. Cancers (Basel). 2024. PMID: 39199666 Free PMC article. Review.
-
Targeted Intracellular Delivery of Antibodies: The State of the Art.Front Pharmacol. 2018 Oct 24;9:1208. doi: 10.3389/fphar.2018.01208. eCollection 2018. Front Pharmacol. 2018. PMID: 30405420 Free PMC article. Review.
-
Demonstration of intracellular trafficking, cytosolic bioavailability, and target manipulation of an antibody delivery platform.Nanomedicine. 2021 Feb;32:102315. doi: 10.1016/j.nano.2020.102315. Epub 2020 Oct 13. Nanomedicine. 2021. PMID: 33065253 Free PMC article.
-
Targeting the Tumour: Cell Penetrating Peptides for Molecular Imaging and Radiotherapy.Pharmaceuticals (Basel). 2010 Mar 11;3(3):600-620. doi: 10.3390/ph3030600. Pharmaceuticals (Basel). 2010. PMID: 27713270 Free PMC article. Review.
-
Cell-penetrating peptides and antibodies: a new direction for optimizing radioimmunotherapy.Eur J Nucl Med Mol Imaging. 2007 Jul;34(7):973-7. doi: 10.1007/s00259-007-0395-4. Eur J Nucl Med Mol Imaging. 2007. PMID: 17453198 No abstract available.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous